Alexion Pharmaceuticals Inc. (ALXN) Thursday announced a decline in second quarter net income to $114.94 million on higher operating and income tax expenses from $170.22 million in the prior year. Earnings per share declined to $0.51 from $0.83 last year. On an adjusted basis, earnings were $1.13 per share.
from RTT - Earnings http://ift.tt/2asKhFC
via IFTTT
No comments:
Post a Comment